9 questions on how to bill for locum tenens services in radiology
Knowing how to properly bill for locum tenens services is essential to maintainin...Read more on AuntMinnie.comRelated Reading: Legal win forces a change to the No Surprises Act What are the practical implications of the No Surprises Act? Coding changes that will impact radiology practices in 2022 How will Medicare payment changes impact your radiology practice? A surprising consequence of the No Surprises Act
Source: AuntMinnie.com Headlines - March 23, 2022 Category: Radiology Source Type: news

A New Process Of SARS-CoV-2 Variation Uncovered: Intragenomic Recombination
The new phenomenon involves intragenomic rearrangements in which segments of various lengths of the untranslated region at the proximal 5 ’ end of the virus, in particular the 5’-leader sequence, are duplicated and translocated into the coding portion of the genome
Source: Forbes.com Healthcare News - March 10, 2022 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news

"Pathological" fractures in spinal cord injuries and disorders: insight into International Classification of Diseases, Ninth Revision coding - Elam R, Doan J, Weaver F, Ray C, Miskevics S, Gonzalez B, Obremskey W, Carbone L.
OBJECTIVE: Analyses of osteoporosis-related fractures in persons with Spinal Cord Injury or Disorder (SCID) using administrative data often exclude pathological fractures (International Classification of Diseases, Ninth Revision (ICD-9) codes 733.1x). We e...
Source: SafetyLit - March 10, 2022 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

EKRA Now Used to Combat Fraudulent COVID-19 Testing, Too
The Department of Justice steps beyond the law’s original focus on opioid-related lab testing fraud An interesting aspect with enforcement of the Eliminating Kickbacks in Recovery Act of 2018 (EKRA) is the government’s willingness to go after charges tied to fraudulent COVID-19 testing.  The case U.S. vs. Malena Badon Lepetich provides a good example of […] The post EKRA Now Used to Combat Fraudulent COVID-19 Testing, Too appeared first on Dark Daily.
Source: Dark Daily - March 9, 2022 Category: Laboratory Medicine Authors: swallask Tags: Clinical Laboratory/ Pathology Coding, Billing, and Collection Resources Coding, Billing, and Collections Compliance, Legal, and Malpractice Laboratory Management and Operations Laboratory News Laboratory Operations Laboratory Pathology Labo Source Type: news

Large Operator of COVID-19 Collection Sites Suspends Operations and Clinical Laboratory Testing Following State and Federal Probes
The post Large Operator of COVID-19 Collection Sites Suspends Operations and Clinical Laboratory Testing Following State and Federal Probes appeared first on Dark Daily.
Source: Dark Daily - March 4, 2022 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: Coding, Billing, and Collections Compliance, Legal, and Malpractice Laboratory Management and Operations Laboratory News Laboratory Pathology Laboratory Testing Akbar Syed Aleya Siyaj anatomic pathology CCC Center for COVID Control c Source Type: news

U.S. FDA Approves CARVYKTI ™ (ciltacabtagene autoleucel), Janssen’s First Cell Therapy, a BCMA-Directed CAR-T Immunotherapy for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
HORSHAM, Pa., February 28, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) has approved CARVYKTI™ (ciltacabtagene autoleucel; cilta-cel) for the treatment of adults with relapsed or refractory multiple myeloma (RRMM) after four or more prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody.1 The approval is based on data from the pivotal CARTITUDE-1 study, which included patients who had received a median of six prior treatment regimens (range, 3-18), and had previously rec...
Source: Johnson and Johnson - March 1, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Imaging groups urge U.S. Congress to reform Medicare system
The American College of Radiology along with other radiology and medical professiona...Read more on AuntMinnie.comRelated Reading: Should second-opinion reads receive more reimbursement? ACR praises CMS for updated lung cancer screening decision Coding changes that will impact radiology practices in 2022 MITA takes aim at CMS proposal to limit Alzheimer's drug coverage Physician groups urge repeal of SGR formula
Source: AuntMinnie.com Headlines - February 28, 2022 Category: Radiology Source Type: news

Transition from Fee-for-Service to Value-Based Reimbursement for Hospitals, Physicians, and Clinical Laboratories Continues, Albeit Slowly, Reports Say  
Medical laboratories and anatomic pathologists may need to squeeze into narrow networks to be paid under value-based schemes, especially where Medicare Advantage is concerned Pathologists have likely heard the arguments in favor of value-based payment versus fee-for-service (FFS) reimbursement models: FFS encourages providers to order medically unnecessary procedures and lab tests. FFS removes incentives for […] The post Transition from Fee-for-Service to Value-Based Reimbursement for Hospitals, Physicians, and Clinical Laboratories Continues, Albeit Slowly, Reports Say  appeared first on Dark Daily.
Source: Dark Daily - February 28, 2022 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: Coding, Billing, and Collections Compliance, Legal, and Malpractice Laboratory Management and Operations Laboratory News Laboratory Pathology Laboratory Testing 4Sight Health alternative payment models AMA american medical association Source Type: news

Coverage is expanded for CT lung cancer screening
The U.S. Centers for Medicare and Medicaid Services has announced a shift i...Read more on AuntMinnie.comRelated Reading: What are the practical implications of the No Surprises Act? Coding changes that will impact radiology practices in 2022 How will Medicare payment changes impact your radiology practice? A surprising consequence of the No Surprises Act Video from RSNA 2021: Regulatory changes for radiology in 2022
Source: AuntMinnie.com Headlines - February 25, 2022 Category: Radiology Source Type: news

Knowing the Origins of COVID-19 Won ’t Change Much
Over two years since the first cases started appearing in Wuhan, China, there is much we don’t know about the origins of SARS-CoV-2, the virus causing COVID-19. But a quick resolution to that question is possible: scientists could find bats in a cave somewhere in China or in southeast Asia and trace a chain leading from those bats to the COVID-19 outbreak in Wuhan. Realistically, however, recent history offers little promise for this to happen quickly. For example, about 14 years elapsed between the identification of HIV as the virus that caused AIDS and a demonstration of its modern transition to humans from a speci...
Source: TIME: Health - February 23, 2022 Category: Consumer Health News Authors: Robert C. Gallo and Dean T. Jamison Tags: Uncategorized COVID-19 Source Type: news

COVID-19 Response: Living with COVID-19, Cabinet Office (updated 23rd February 2022)
This document outlines the government ' s plan for living with COVID-19, which - underpinned by vaccines - will remove the remaining legal domestic restrictions while continuing to protect people most vulnerable to COVID-19 and maintaining resilience. 23 February 2022Added HTML version of ' COVID-19 Response: Living with COVID-19 ' . 21 February 2022First published.
Source: Current Awareness Service for Health (CASH) - February 23, 2022 Category: Consumer Health News Source Type: news

He started coding for his startup in high school. Now the business aims to save hospitals hundreds of millions.
RevQuest Inc. has grown to 30 employees and is on track this year to recover more than $450 million for hospitals and health systems by correcting billing errors, CEO Keith Moody said.
Source: bizjournals.com Health Care News Headlines - February 18, 2022 Category: Health Management Authors: Carrie Ghose Source Type: news

Scientific evidence supporting the government response to coronavirus (COVID-19), SAGE (updated 18th February 2022)
Evidence considered by the Scientific Advisory Group for Emergencies (SAGE). 18 February 2022We ' ve added 10 new papers to February 2022 and added an HTML version of one paper. We ' ve also corrected the author attribution of a paper from April 2020. 11 February 2022Added link to February 2022 SAGE document collection.
Source: Current Awareness Service for Health (CASH) - February 18, 2022 Category: Consumer Health News Source Type: news

What are the practical implications of the No Surprises Act?
The No Surprises Act (NSA) has been in effect in the U.S. for a few weeks, an...Read more on AuntMinnie.comRelated Reading: ACR seeks summary judgment in No Surprises Act suit Coding changes that will impact radiology practices in 2022 How will Medicare payment changes impact your radiology practice? ACR sues to block No Surprises Act A surprising consequence of the No Surprises Act
Source: AuntMinnie.com Headlines - February 17, 2022 Category: Radiology Source Type: news

Janssen Presents New Data Demonstrating the Combination of Niraparib and Abiraterone Acetate Plus Prednisone Significantly Improved Radiographic Progression-Free Survival as a First-Line Therapy in Patients with HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer
SAN FRANCISCO, Feb. 14, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced initial results from the Phase 3 MAGNITUDE study evaluating the investigational use of niraparib, a selective poly-ADP ribose polymerase (PARP) inhibitor, in combination with abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) with or without specific homologous recombination repair (HRR) gene alterations. At the final analysis for radiographic progression-free survival (rPFS), the treatment combination of niraparib and abiraterone acetate plus prednisone de...
Source: Johnson and Johnson - February 14, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20